InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,839.96
(
-0.34%
)
US TECH 100
19,717.60
(
-0.92%
)
Dow Jones
42,874.12
(
-0.44%
)
Brent Oil
73.57
(
-1.80%
)
Bitcoin
65,687.49
(
-0.57%
)
Post# of 77519
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

EZ2

Send PM Follow Ignore
Followers 213
Posts 219159
Boards Moderated 2
Alias Born 03/31/2001

EZ2

Re: EZ2 post# 54037

Wednesday, 01/02/2013 10:05:35 AM

Wednesday, January 02, 2013 10:05:35 AM

Post# of 77519

On the biotech side, MMR received two additional patents for our anti-CD20 antibodies and B-Cell vaccine in Mexico. We also received a patent in Mexico for our Personal Health Record health IT service offerings. As a result of the Company’s intellectual property portfolio, we have already received more than one million dollars in license fees and signed numerous biotech and health IT licensing agreements which already call for payments in excess of 40 million dollars over the next four years.

“It's almost worth the Great Depression to learn how little our big men know.”

~ Will Rogers

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up